
OLD Category: Oncology
September 8, 2020 / eLife
A perspective on HPK1 as a novel immuno-oncology drug target
September 8, 2020 / Neuro Oncol
Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma
September 5, 2020 / Pathol Res Pract
Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?
September 3, 2020 / PLoS One
Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training
September 2, 2020 / Front Oncol
Immune-Related Gene Expression and Cytokine Secretion Is Reduced Among African American Colon Cancer Patients
September 1, 2020 / Cancers (Basel)
Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
September 1, 2020 / Cancers (Basel)
CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge
September 1, 2020 / JCO Precision Oncology